Patent · US Active

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

US8796319B2 · kind B2 · utility

14Cited by

19References

68Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Andrew P. Combs · Kennett Square, US
Eddy W. Yue · Landenberg, US
Richard B. Sparks · Linwood, US
Wenyu Zhu · Wilmington, US
Jiacheng Zhou · Shanghai, CN
Qiyan Lin · Newark, US
Lingkai Weng · Malvern, US
Tai-Yuen Yue · Hockessin, US
Pingli Liu · Wilmington, US

Key dates

Filing date	Nov 11, 2011
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Nov 11, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.